Skip to content

Legal status · Australia

Is Ruxolitinib legal in Australia?

Written by Reviewed Sep 2026

ApprovedAnti-agingStudies in people cited: 2

Direct answer

Yes. Ruxolitinib is an approved medicine in Australia. Its legal category is "TGA-registered, prescription only". The approval covers the use on its label. It is given out on prescription, not sold over the counter. Products labeled "research use only" are not covered by that approval, and that label does not make them legal to use in people. On the evidence, 1 completed human trial is cited on its profile.

People given it
309
Found nothing
0

Legal category

TGA-registered, prescription only

TGA-registered as Jakavi. Prescription only.

Reviewed Sep 2026. This is a legal category, not legal advice.

A "research use only" label on a vial does not make it legal to use on people.

Ruxolitinib in Australia at a glance

Legal categoryTGA-registered, prescription only
NoteTGA-registered as Jakavi. Prescription only.
TGA approval statusApproved by TGA for the use on its label
Studies in people2 of 4 sources on the profile
ReviewedSep 2026

The legal category and note come from the Ruxolitinib profile. We checked them against Therapeutic Goods Administration (TGA) listings on the reviewed date.

What this means

  • 01

    TGA has approved Ruxolitinib for at least one use named on its label. So a proper pharmacy-grade product exists in Australia, and pharmacies hand it out on prescription.

  • 02

    Approval covers only the uses named on the label. Any other use is a prescriber's call. The approval itself does not cover it.

  • 03

    Unlicensed vials sold online, including those labeled "research use only", are not the approved product. The approval does not cover them.

What Ruxolitinib is

An approved drug that blocks two signalling enzymes, JAK1 and JAK2. In old mice it quieted the inflammatory signals from worn-out 'zombie' cells and helped them move better. All of its human evidence is in myelofibrosis, a bone marrow cancer, where it shrinks swollen spleens. The cream version carries the FDA's strongest warning, for serious infections, death, cancer, heart problems and blood clots.

Ruxolitinib is the clearest example of a 'senomorphic' rather than a senolytic. A senolytic kills zombie cells.

How it works: Ruxolitinib blocks JAK1 and JAK2, two enzymes inside the cell that pass on signals from a big family of immune messenger receptors. Much of the inflammatory output of zombie cells is made and kept going through that pathway.

Approval history: FDA-approved as Jakafi pills for two bone marrow cancers, myelofibrosis and polycythaemia vera. Jakafi is also approved for graft-versus-host disease, where donor cells from a transplant attack the body, when steroids have not worked. That covers both sudden and long-term forms. It is also approved as Opzelura cream for eczema (atopic dermatitis) and for the common form of vitiligo (non-segmental). Not approved for ageing, frailty or clearing worn-out cells, and not in a registered trial for any of those.

How TGA treats this kind of product

Registers or lists medicines and health products on the ARTG, its official register. It also sorts substances into schedules in the Poisons Standard. Many peptides are Schedule 4 (prescription only). So having them without a prescription, or importing them for yourself, is restricted. That is true even when no product is registered.

The legal category above is how The Longevity Archive reads Therapeutic Goods Administration listings for Ruxolitinib on the reviewed date. It is not a legal opinion. Rules change. Bringing a compound into the country, prescribing it and owning it can each be treated differently. Check with the agency before you act on anything here.

Check TGA directly

Ruxolitinib in sport and the military

Whether Ruxolitinib is banned in sport is set by the World Anti-Doping Code and by military rules, not by its legal status in Australia. Before you compete or get tested, look up Ruxolitinib by name on the Prohibited List, or look up a named product in Global DRO. Under the World Anti-Doping Code, category S0 bans, at all times, any drug-like substance that meets two tests. No other section of the List covers it. And no government health regulator anywhere has a current approval for it as a treatment in people. Many substances that are approved somewhere are banned by name in another section. So approval does not mean a substance is allowed in sport.

The rules you compete or serve under decide this, not this page.

Ruxolitinib in other countries

Frequently asked questions

Is Ruxolitinib legal in Australia?

Yes. Ruxolitinib is an approved medicine in Australia. Its legal category is "TGA-registered, prescription only". The approval covers the use on its label. It is given out on prescription, not sold over the counter. Products labeled "research use only" are not covered by that approval, and that label does not make them legal to use in people. On the evidence, 1 completed human trial is cited on its profile. Note: TGA-registered as Jakavi. Prescription only.

Can I buy Ruxolitinib in Australia?

Only with a prescription. In Australia, Ruxolitinib has the legal category "TGA-registered, prescription only". Pharmacies hand it out with a prescription, for the use it is approved for. Buying it from unlicensed sellers online, or as a "research chemical", is outside that system. You get none of the protection the regulator gives. Note: TGA-registered as Jakavi. Prescription only.

Is Ruxolitinib TGA approved?

Yes, for the use on its label. In Australia, Ruxolitinib has the legal category "TGA-registered, prescription only". For comparison, its US FDA status is: FDA-approved as Jakafi pills for two bone marrow cancers, myelofibrosis and polycythaemia vera. Jakafi is also approved for graft-versus-host disease, where donor cells from a transplant attack the body, when steroids have not worked. That covers both sudden and long-term forms. It is also approved as Opzelura cream for eczema (atopic dermatitis) and for the common form of vitiligo (non-segmental). Not approved for ageing, frailty or clearing worn-out cells, and not in a registered trial for any of those.. On the evidence, 1 completed human trial is cited on its profile.

Related compounds in Australia

Full research profile

How Ruxolitinib works, the studies we cite, FDA status and the full legal summary are all on its compound profile.

Ruxolitinib profile

This page is general information about the legal status of Ruxolitinib in Australia, current as of Sep 2026. It is not legal advice. Legal status changes. For your own situation, check with Therapeutic Goods Administration or ask a lawyer. Educational use only. This database summarizes published research and is not medical advice. Where a dose appears it is a record of what a trial or clinic ran, or what people describe doing, with its source attached. Nothing here is a recommendation for personal use. Sellers named on the price pages are ranked by certificate tier, then price, and any affiliate income is disclosed there. Naming a seller is not a recommendation to buy or use anything.